Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Opipramol - Novartis

Next Previous
Drug Profile

Opipramol - Novartis

Alternative Names: Ensidon; G 33040; Insidon; Nisidana; OPIprol

Latest Information Update: 13 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis
  • Developer Novartis; Sun Pharmaceutical Industries
  • Class Dibenzazepines; Small molecules; Tricyclic antidepressants
  • Mechanism of Action Dopamine D2 receptor antagonists; Histamine H1 receptor antagonists; Opioid receptor agonists; Serotonin 5-HT2 receptor antagonists; Sigma-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Generalised anxiety disorder; Major depressive disorder
  • No development reported Somatoform disorders

Most Recent Events

  • 13 Nov 2025 Launched for Generalised anxiety disorder in India (PO)
  • 08 Apr 2021 Opipramol is approved for Generalized anxiety disorder in India
  • 13 Jan 2004 No development reported - Clinical-Phase-Unknown for Somatoform disorders in Germany (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top